Almirall S.A.

Research activity is centred on moderate-to-severe atopic dermatitis, with additional interest in nummular dermatitis and broader eczema management in adults and adolescents. The sponsor’s portfolio reflects sustained attention to disease control, symptom relief, and longer-term treatment use in chronic inflammatory skin disease.

• Atopic dermatitis
• Nummular dermatitis
• Chronic inflammatory skin disease

These studies focus on persistent cutaneous inflammation and the clinical burden of recurrent pruritus, erythema, and skin barrier dysfunction.